FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) recall — FDA Z-2563-2025
Their is the potential for weak staining which may result in false negative CD20 identification.
Overview of recall records associated with Agilent Technologies Denmark ApS, including dates, categories and classifications where available.
Classification mix: Class II: 3.
Their is the potential for weak staining which may result in false negative CD20 identification.
Their is the potential for weak staining which may result in false negative CD20 identification.
Their is the potential for weak staining which may result in false negative CD20 identification.
This page summarizes recall records in which the official source identifies Agilent Technologies Denmark ApS as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.